Search | Clinical Trials Finder

Conditions: Sleep Apnea, Obstructive, Hypotonia, Child, Only
Interventions: ssNPA; Device
Lead sponsor: University of Michigan; Other
Eligibility: 3 Years to 21 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Nasal Obstruction, Rhinitis, Vasomotor, Epistaxis
Interventions: Saline mixture; Other
Lead sponsor: Lisa Shnayder; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Health Knowledge, Attitudes, Practice, Sneezing, Constipation, Nasal Congestion and Inflammations
Interventions: Intensified anticipatory guidance, Routine; Behavioral
Lead sponsor: Bronx-Lebanon Hospital Center Health Care System; Other
Eligibility: Female only
Enrollment: 323 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Upper Airway Obstruction
Interventions: McMurray Enhanced Airway; Device
Lead sponsor: McMurray Medical Group, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 86 participants
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Nasal Obstruction
Interventions: Vibrissae trimming, Application of oxymetazoline; Procedure · Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Common Cold, Pharyngitis
Interventions: Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine, Acetylsalicylic Acid (Aspirin, BAYE4465), Pseudoephedrine, Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 1,016 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 2
States / cities: New York, New York

Conditions: Esophageal Foreign Body, Esophageal Obstruction
Interventions: Point of care ultrasound; Diagnostic Test
Lead sponsor: WellSpan Health; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: York, Pennsylvania

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Non-interventional study.; Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years and older
Enrollment: 1,283 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 47
States / cities: Highlands Ranch, Colorado • Wheat Ridge, Colorado • Clearwater, Florida + 43 more

Conditions: Intubation; Difficult or Failed, Airway Obstruction
Interventions: I View Video Laryngoscope https://www.intersurgical.com/content/files/108253/-1977057700; Device
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 168 participants
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Denver, Colorado • San Antonio, Texas

Conditions: Nasal Obstruction
Interventions: Nasal Plug; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 330 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Peyronie's Disease
Interventions: Subjects Previously Treated with AA4500; Drug
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years to 90 Years · Male only
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 30
States / cities: Anchorage, Alaska • Burbank, California • Laguna Hills, California + 27 more

Conditions: Airway Obstruction, Apnea, Hypopnea
Interventions: Airway Management System (AMS); Device
Lead sponsor: 5i Sciences, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Hypotonia, Muscle, Obstructive Sleep Apnea, Nasal Airway Obstruction
Interventions: Self-Supporting Nasopharyngeal Airway (ssNPA); Device
Lead sponsor: University of Michigan; Other
Eligibility: 3 Years to 23 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Ear Deformities, Acquired, Ear; Deformity, Congenital, Microtia, Nose Deformity, Nose Deformities, Acquired, Nose; Deformity, Congenital, Nose; Deformity, Congenital, Bent or Squashed, Nose; Deformity, Syphilitic, Congenital, Nose; Deformity, Bone (Nose Cartilage), Nose; Deformity, Septum, Congenital, Nose; Deformity, Sinus (Wall), Congenital, Nose; Deformity, Syphilitic, Late (Etiology), Ear; Deformity, External, Ear; Deformity, Auricle, Ear, Acquired, Ear; Deformity, Auricle, Ear (Congenital)
Interventions: AuryzoN Family of Devices; Device
Lead sponsor: Reconstrata, LLC; Industry
Eligibility: Not listed
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Pain, Anxiety, Chronic Rhinosinusitis (CRS), Nasal Obstruction, Nasal Polyp, Eustachian Tube Dysfunction, Dysphonia, Subglottic Stenosis (SGS)
Interventions: Virtual reality headset or goggles; Device
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Subglottic Stenosis (SGS), Pierre Robin Sequence (PRS), Micrognathia, Normal Controls From CT Scans of the Upper Airway
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: Up to 17 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Lung Neoplasms, Respiratory Failure, Pneumonia, Acute Coronary Syndromes, Unstable Angina, Myocardial Infarction, Cardiac Arrhythmia, Thromboembolic Disease
Interventions: Normal Saline, Sodium Bicarbonate; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Nasal Obstruction
Interventions: Microdebrider-Assisted Inferior Turbinoplasty (MAIT), Submucous Resection with non powered instrument; Procedure
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 70 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Oxygen Desaturation, Apnea (Central and Obstructive), Airway Obstruction
Interventions: Breath-synchronized oxygen, CPAP, Control; Device
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: South Jordan, Utah

Conditions: Airway Obstruction
Interventions: McMurray Enhanced Airway, Nasal Cannula; Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Lung Cancer
Interventions: Medical Data Collection; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Nasal Obstruction
Interventions: Vivaer Stylus; Device
Lead sponsor: Aerin Medical; Industry
Eligibility: 22 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 9
States / cities: Fresno, California • Colorado Springs, Colorado • Oradell, New Jersey + 6 more

Conditions: Nasal Congestion
Interventions: Sonu Acoustic Resonance Therapy; Device
Lead sponsor: Third Wave Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Aclidinium bromide/formoterol Fixed-Dose Combination (FDC), Aclidinium bromide, Formoterol Fumarate, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 40 Years and older
Enrollment: 921 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 179
States / cities: Anniston, Alabama • Athens, Alabama • Birmingham, Alabama + 146 more

Search by objective public record fields.

Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia

Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer

"Anticipatory Guidance in the Nursery and Its Impact on Non-urgent Emergency Department Visits"

A New Flexible Extended-Length Pharyngeal Airway for Deep Sedation

The Effect of Nasal Hair on Nasal Obstruction

Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine

Point of Care Ultrasound for the Detection of Esophageal Food Bolus

Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath

Comparing iView Video Laryngoscope in the Emergency Department

Nasal Obstruction and Olfactory Losses

Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease

Effectiveness of Continuous Negative External Pressure in Preventing Upper Airway Impairment During Routine Colonoscopy

Long-term Evaluation of Nasopharyngeal Airway in Hypotonia

Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures

Active vs. Passive VR During Office-based ENT Procedures

Functional Modeling of the Pediatric Airway

Clearance Of Mucus In Stents (COMIS)

Trial Comparing Microdebrider-Assisted Inferior Turbinoplasty (MAIT) vs Submucous Resection (SMR)

Supplemental Oxygen and Oxygen Desaturations in Colonoscopies

The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE

Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction

Treatment of Nasal Airway Obstruction Using the Aerin Medical Device

Sonu Real-World Use Clinical Study to Treat Moderate to Severe Nasal Congestion

Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)